Comparison of 2 effect-site concentrations of remifentanil with midazolam during percutaneous transluminal balloon angioplasty under monitored anesthesia care: A randomized controlled study.
Hou-Chuan LaiYi-Ting TsaiYi-Hsuan HuangKe-Li WuRen-Chih HuangBo-Feng LinShun-Ming ChanWei-Hung ChanPublished in: Medicine (2021)
In percutaneous transluminal balloon angioplasty for dysfunctional hemodialysis fistulas, target-controlled infusion with remifentanil Minto model target 2.0 ng/mL with 3 to 4 mg midazolam use provided appropriate hemodynamic conditions, sufficient sedation and analgesia, and acceptable apnea with desaturation.